Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the most common disorder of mitochondrial fatty acid β-oxidation and a target disease of newborn screening in many countries. This evidence concerns the gene ACADM and medium chain acyl-CoA dehydrogenase deficiency.